Healthcare covers pharmaceutical companies, medical devices, plus biotechnology. Demand for treatment as well as medicine is fairly independent of the economy, which gives the sector a defensive character. At the same time, individual research companies can swing sharply on trial results or regulatory decisions. The sector appeals if you want a stable base of large, profitable companies, perhaps combined with a few more aggressive growth names.